Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 24 March 2006: Vol. 311. no. 5768, pp. 1688 - 1689 DOI: 10.1126/science.311.5768.1688
|
|
News of the Week
DRUG TRIALS: Violent Reaction to Monoclonal Antibody Therapy Remains a Mystery
Eliot Marshall
CAMBRIDGE, U.K.--On 13 March, six healthy volunteers in a clinical trial were injected with a "superagonist," a drug meant to boost a type of T cell in the immune system, and soon all of them became violently ill. Exactly what triggered the reaction is not known. (Read more.)
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Ex Vivo Expansion of CD4+CD25+FoxP3+ T Regulatory Cells Based on Synergy between IL-2 and 4-1BB Signaling.
- K. G. Elpek, E. S. Yolcu, D. D. H. Franke, C. Lacelle, R.-H. Schabowsky, and H. Shirwan (2007)
J. Immunol.
179, 7295-7304
| Abstract »
| Full Text »
| PDF »
- Biologics in the Pipeline: Large Molecules With High Hopes or Bigger Risks?.
- H. Zhou (2007)
J. Clin. Pharmacol.
47, 550-552
| Full Text »
| PDF »
- Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development.
- M. A. Mascelli, H. Zhou, R. Sweet, J. Getsy, H. M. Davis, M. Graham, and D. Abernethy (2007)
J. Clin. Pharmacol.
47, 553-565
| Abstract »
| Full Text »
| PDF »
- Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice.
- L. Niu, S. Strahotin, B. Hewes, B. Zhang, Y. Zhang, D. Archer, T. Spencer, D. Dillehay, B. Kwon, L. Chen, et al. (2007)
J. Immunol.
178, 4194-4213
| Abstract »
| Full Text »
| PDF »
- Regulatory T Cell Vaccination without Autoantigen Protects against Experimental Autoimmune Encephalomyelitis.
- J. Ochoa-Reparaz, C. Riccardi, A. Rynda, S. Jun, G. Callis, and D. W. Pascual (2007)
J. Immunol.
178, 1791-1799
| Abstract »
| Full Text »
| PDF »
|
|